PembrolizumabMyasthenia gravis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1764卷 / 1期

关键词：

D O I：

10.1007/s40278-019-65692-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：268 / 268

相关论文

共 50 条

[41] PembrolizumabMyasthenia gravis and myositis
Reactions Weekly, 2024, 2014 (1) : 554 - 554
[42] Immune-globulin/methylprednisolone/pembrolizumabMyasthenia-gravis and lack of efficacy: case report
Reactions Weekly, 2021, 1870 (1) : 159 - 159
[43] PembrolizumabMyasthenia gravis, myositis and myocarditis
Reactions Weekly, 2024, 2014 (1) : 555 - 555
[44] SotalolMyasthenia gravis: case report
Reactions Weekly, 2019, 1778 (1) : 421 - 421
[45] NivolumabMyasthaenia gravis: case report
Reactions Weekly, 2019, 1773 (1) : 257 - 257
[46] RegorafenibMyasthenia gravis: case report
Reactions Weekly, 2023, 1953 (1) : 350 - 350
[47] NivolumabMyasthenia gravis: case report
Reactions Weekly, 2019, 1774 (1) : 241 - 241
[48] HydroxychloroquineMyasthenia gravis: case report
Reactions Weekly, 2019, 1737 (1) : 152 - 152
[49] PenicillamineMyasthenia gravis: case report
Reactions Weekly, 2012, 1424 (1) : 41 - 41
[50] TislelizumabMyasthenia gravis: case report
Reactions Weekly, 2024, 2025 (1) : 437 - 437

← 1 2 3 4 5 →